Birads 3 Tumors on the Ultrasound: Oncological Risks

Introduction . BIRADS 3 tumors are an area of interest for the oncologist and the gynecologist considering likelihood of cancer less than or equal to 2%. Aim. To analyze the frequency of diagnoses in BIRADS 3 of ultrasound, to determine the risk of breast cancer in women with BIRADS 3 after the first ultrasound. Materials and methods . A prospective study was carried out, the participants of were women from the TransBaikal Regional Oncology Center with BIRADS 3 after the first ultrasound.expert-class ultrasound examination of the breast was carried out for all patients using a General Electric Voluson E6 device (Austria, 2011).The fine-needle aspiration biopsy (FNA) with cytological examination, core tumor biopsy (Biopsy needle, Italy, 14 G / 2.00 mm) with histological examination were performed according to indications.Statistical analysis was carried out using the IBM SPSS Statistics Version 25.0 program" Results . Almost every third of the woman referred to an oncologist does not have a BIRADS gradation in the ultrasound report. Changing the BIRADS category was performed in 22.4% of cases after expert ultrasound Biopsy of tumors with the BIRADS 3 was performed in 31% cases, among them breast cancer was detected in 3,4% of cases, intraductal papilloma with atypia – 1,7%. Conclusion . The use of BIRADS grading is necessary for the breast ultrasound, which affects the routing and examination. The management for patients with BIRADS 3 ultrasound should be individualized, considering clinical, radiological features.